KRS Capital Management »

Vertex Pharmaceuticals Incorporated shares owned by KRS Capital Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by KRS Capital Management from 13F filings

Historical chart of KRS Capital Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by KRS Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by KRS Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $739k 1.8k 418.01
2023-12-31 $719k 1.8k 406.89
2023-09-30 $615k 1.8k 347.74
2023-06-30 $622k 1.8k 351.91
2023-03-31 $565k 1.8k 315.07
2022-12-31 $460k 1.6k 288.78
2022-09-30 $403k 1.4k 289.51
2022-06-30 $357k 1.3k 281.77
2022-03-31 $330k 1.3k 260.46
2021-12-31 $245k 1.1k 219.34

More positions owned by KRS Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Fortinet (FTNT)
Meta Platforms Cl A (META)
Palo Alto Networks (PANW)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Qualcomm (QCOM)
Alphabet Cap Stk Cl A (GOOGL)
salesforce (CRM)
Abbvie (ABBV)
Honeywell International (HON)
JPMorgan Chase & Co. (JPM)

View all positions for KRS Capital Management

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated